AMGN

Amgen Inc. is a fully integrated biotechnology company that discovers, develops, manufactures and commercializes prescription medicines, primarily biologics, for serious illnesses such as cancer, cardiovascular disease, inflammation, bone health and rare diseases. It operates in the biotechnology and pharmaceutical sector, leveraging human genetics, large‑scale biomanufacturing and a growing biosimilars business to fund its pipeline of innovative therapies. Amgen is one of the world’s largest independent biotech firms, with a global commercial footprint and a portfolio that includes long‑standing blockbuster biologics as well as newer specialty drugs and acquired rare‑disease treatments. Its dual focus on novel biologics and off‑patent biosimilars positions it as a major player in both high‑growth innovation and steady‑revenue streams within the industry.